The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses

Creative Commons License

Dolgun Z. N., Kabaca C., Karateke A., Iyibozkurt C., Inan C., Altintas A. S., ...Daha Fazla

BALKAN MEDICAL JOURNAL, cilt.34, sa.2, ss.156-162, 2017 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/balkanmedj.2016.0223
  • Dergi Adı: BALKAN MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.156-162
  • Anahtar Kelimeler: Tumour marker, ovarian cancer, adnexal mass, human epididymis 4, cancer antigen 125, EPITHELIAL OVARIAN-CANCER, HE-4, PROTEIN, CARCINOMA, ALGORITHM, CA125, SYMPTOMS, MULTIPLE, RISK, ROMA
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Ovarian cancer is one of the highest mortality cancers in gynaecology. Discrimination of benign masses from malignant ones may sometimes become a challenge for the clinician since there is not a reliable tumour marker, thus some unnecessary, highly morbid operations can be performed.